Skopos Labs, Inc. Ironwood Pharmaceuticals Inc Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,293 shares of IRWD stock, worth $8,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,293Holding current value
$8,392% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
235Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$83.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$80.7 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$60 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$41.3 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$36.3 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $561M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...